| For: | Razonable RR. Cytomegalovirus infection after liver transplantation: Current concepts and challenges. World J Gastroenterol 2008; 14(31): 4849-4860 [PMID: 18756591 DOI: 10.3748/wjg.14.4849] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i31/4849.htm |
| Number | Citing Articles |
| 1 |
Panagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, Marta Miarons, Beatriz Fernández-Alarcon, Oriol Bestard, Josep M. Cruzado, Edoardo Melilli, Joan Torras, Josep M. Grinyó, Nuria Lloberas, Helena Colom. Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population Approach. Clinical Pharmacokinetics 2023; 62(6) doi: 10.1007/s40262-023-01237-3
|
| 2 |
Jay A. Fishman, Robin K. Avery. Textbook of Organ Transplantation. 2014; doi: 10.1002/9781118873434.ch94
|
| 3 |
G. Erwin Buckel, G. Andrea Alba. Dieciséis años de experiencia de trasplante hepático en clínica las condes. Revista Médica Clínica Las Condes 2010; 21(2) doi: 10.1016/S0716-8640(10)70533-2
|
| 4 |
Michael Barry. Single-cycle adenovirus vectors in the current vaccine landscape. Expert Review of Vaccines 2018; doi: 10.1080/14760584.2018.1419067
|
| 5 |
B. Sharmila Mohanraj, Amol S. Rangnekar, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases. 2019; doi: 10.1007/978-1-4939-9034-4_3
|
| 6 |
Narendra S. Choudhary, Sanjiv Saigal, Rajat Shukla, Hardik Kotecha, Neeraj Saraf, Arvinder S. Soin. Current Status of Immunosuppression in Liver Transplantation. Journal of Clinical and Experimental Hepatology 2013; 3(2) doi: 10.1016/j.jceh.2013.04.005
|
| 7 |
R.J. Arasaratnam, I. Tzannou, T. Gray, P.I. Aguayo-Hiraldo, M. Kuvalekar, S. Naik, A. Gaikwad, H. Liu, T. Miloh, J.F. Vera, R.W. Himes, F.M. Munoz, A.M. Leen. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. American Journal of Transplantation 2018; 18(9) doi: 10.1111/ajt.14967
|
| 8 |
Nurettin Dogan, Anna Hüsing-Kabar, Hartmut H. Schmidt, Vito R. Cicinnati, Susanne Beckebaum, Iyad Kabar. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. Journal of International Medical Research 2018; 46(9) doi: 10.1177/0300060518785543
|
| 9 |
Augustine J. Sohn, Hoonbae Jeon, Joseph Ahn. Primary Care of the Liver Transplant Recipient. Primary Care: Clinics in Office Practice 2011; 38(3) doi: 10.1016/j.pop.2011.05.006
|
| 10 |
Sari R. Freedman, Kenneth Saunders, Michael E. Plazak, Bharath R. Ravichandran, Kapil K. Saharia, Brian M. Masters, Tracy Sparkes. Impact of high MELD scores on CMV viremia following liver transplantation. Transplant Infectious Disease 2023; 25(1) doi: 10.1111/tid.14001
|
| 11 |
Murat Aral, Ayfer Bakır, Cemal Çiçek, Elif Tuğçe Güner, Didem Özkan, Muhammed Furkan Kürkçü, Gülşah Ceylan Yağız, Mehmet Morkoç, Ferit Kulalı, Ahmet Kürşad Güneş. Analytical Performance and Inter-Method Agreement of a Laboratory-Developed CMV qPCR Assay in Clinical Plasma Samples. Microorganisms 2026; 14(5) doi: 10.3390/microorganisms14051127
|
| 12 |
Shanna Kowalsky, Ronen Arnon, Roberto Posada. Prevention of cytomegalovirus following solid organ transplantation: A literature review. Pediatric Transplantation 2013; 17(6) doi: 10.1111/petr.12118
|
| 13 |
David Herman, Hyosun Han. Cytomegalovirus in liver transplant recipients. Current Opinion in Organ Transplantation 2017; 22(4) doi: 10.1097/MOT.0000000000000433
|
| 14 |
Yuliang Wang, Yawu Liu, Ruifa Han, Qiang Li, Zhi Yao, Wenyan Niu, Yuhua Yuan, Zhiqin Tang, Zhijun Zhu, Zhongyang Shen. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation. Journal of Gastroenterology and Hepatology 2010; 25(1) doi: 10.1111/j.1440-1746.2009.05966.x
|
| 15 |
T. Coulson, J. Wendon. Réanimation hépatosplanchnique. 2010; doi: 10.1016/B978-2-8101-0186-3.50004-7
|
| 16 |
Curtis D. Holt, Drew J. Winston. Transplantation of the Liver. 2015; doi: 10.1016/B978-1-4557-0268-8.00078-6
|
| 17 |
Anita S. Chong, Maria-Luisa Alegre. The impact of infection and tissue damage in solid-organ transplantation. Nature Reviews Immunology 2012; 12(6) doi: 10.1038/nri3215
|
| 18 |
Udayakumar Navaneethan, Preethi G.K. Venkatesh, Jiang Wang. Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBD. Journal of Crohn's and Colitis 2011; 5(4) doi: 10.1016/j.crohns.2011.01.010
|
| 19 |
Qingbao Ding, Keyu Wang, Yupeng Li, Peng Peng, Dongyuan Zhang, Donglei Chang, Wentao Wang, Lei Ren, Fang Tang, Ziqiang Li. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation. American Journal of Clinical Oncology 2023; 46(7) doi: 10.1097/COC.0000000000001004
|
| 20 |
P. Spagnolo, S. Zeuzem, L. Richeldi, R. M. Du Bois. The complex interrelationships between chronic lung and liver disease: a review. Journal of Viral Hepatitis 2010; 17(6) doi: 10.1111/j.1365-2893.2010.01307.x
|
| 21 |
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; doi: 10.1007/978-94-007-7745-3_40-1
|
| 22 |
Lee R. Wright, Dennis L. Wright, Sandra K. Weller. Viral Nucleases from Herpesviruses and Coronavirus in Recombination and Proofreading: Potential Targets for Antiviral Drug Discovery. Viruses 2022; 14(7) doi: 10.3390/v14071557
|
| 23 |
Rohit Talwani, Bruce L. Gilliam, Charles Howell. Infectious Diseases and the Liver. Clinics in Liver Disease 2011; 15(1) doi: 10.1016/j.cld.2010.09.002
|
| 24 |
C. Camus. Complications infectieuses chez le transplanté hépatique. Réanimation 2014; 23(3) doi: 10.1007/s13546-014-0888-7
|
| 25 |
G.W. Kang, H.L. Hong, I.H. Lee, K.S. Ahn, J.D. Kim, D.L. Choi. Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report. Transplantation Proceedings 2016; 48(4) doi: 10.1016/j.transproceed.2016.01.021
|
| 26 |
Bongkun Choi, Eun-Ju Chang. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; doi: 10.1007/978-94-007-7742-2_32-1
|
| 27 |
Stefan G. Hübscher, Andrew D. Clouston. MacSween's Pathology of the Liver. 2012; doi: 10.1016/B978-0-7020-3398-8.00015-5
|
| 28 |
Fawaz D Alshammari. Association between HPV, CMV, EBV and HS Viruses and Breast Cancer in Saudi Arabia. Journal of Cancer Prevention & Current Research 2017; 7(3) doi: 10.15406/jcpcr.2017.07.00236
|
| 29 |
Herlinda Reyes-Pérez, José Luis Sánchez-Huerta, Gustavo Varela-Fascinetto, José Carlos Romo-Vázquez, Abigail Morales-Sánchez, Ezequiel M. Fuentes-Pananá, Israel Parra-Ortega, Graciela Ramírez-Ramírez, Briceida López-Martínez. Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients. Boletín Médico del Hospital Infantil de México 2016; 73(1) doi: 10.1016/j.bmhimx.2015.12.006
|
| 30 |
A.C. Guardia-Silva, R.S.B. Stucchi, A.M. Sampaio, A. Milan, S.C.B. Costa, I.F.S.F. Boin. Detection of Cytomegalovirus and Human Herpesvirus-6 DNA in Liver Biopsy Specimens and Their Correlation With Rejection After Liver Transplantation. Transplantation Proceedings 2012; 44(8) doi: 10.1016/j.transproceed.2012.07.027
|
| 31 |
Yumi Aoyama, Seiko Sugiyama, Takenobu Yamamoto. Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions. Pharmaceuticals 2022; 15(7) doi: 10.3390/ph15070797
|
| 32 |
Amir Nasimfar, Ebrahim Sadeghi, Abdolvahab Alborzi, Nariman Sepehrvand, Mazyar Ziyaeyan, Marzieh Jamalidoust, Sayed Ali Malek-Hosseini. The Activation of Cytomegalovirus and Human Herpes Virus 6 After Liver Transplantation. Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.11987
|
| 33 |
W.C. Palmer, C.B. Taner, A.P. Keaveny, R.E. Nakhleh, J.H. Nguyen, B.G. Rosser. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplantation Proceedings 2018; 50(10) doi: 10.1016/j.transproceed.2018.09.001
|
| 34 |
Kentaro Ushijima, Yukihiro Sanada, Shinya Otomo, Keiko Ogaki, Taiichi Wakiya, Noriki Okada, Yuta Hirata, Toshio Horiuchi, Takahiko Omameuda, Kiichiro Takadra, Ryosuke Akimoto, Yasuharu Onishi, Yasunaru Sakuma, Koichi Mizuta. Inherited metabolic diseases are a potent risk factor for cytomegalovirus infection in pediatric living donor liver transplantation. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-10507-3
|
| 35 |
Li Zhuang, Sheng-Jun Xu, Dong Chen, Zhen-Bin Ding, Jing-Yang Gu, Dong-Hua Liu, Yan-Hua Lai, Wei Qiu, Feng Wang, Guang-Sheng Yu, Zi-Qiang Li, Chi-Yu He, Qing-Yang Que, Shu-Sen Zheng, Xiao Xu. Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients. Hepatobiliary & Pancreatic Diseases International 2026; doi: 10.1016/j.hbpd.2026.05.006
|
| 36 |
Irmeli Lautenschlager. CMV infection, diagnosis and antiviral strategies after liver transplantation. Transplant International 2009; 22(11) doi: 10.1111/j.1432-2277.2009.00907.x
|
| 37 |
Raymund R. Razonable, Ajit P. Limaye. Transplant Infections. 2016; doi: 10.1007/978-3-319-28797-3_25
|
| 38 |
|
| 39 |
Nina Singh, Drew J Winston, Raymund R Razonable, G Marshall Lyon, Fernanda P Silveira, Marilyn M Wagener, Ajit P Limaye. Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors. Clinical Infectious Diseases 2021; 73(9) doi: 10.1093/cid/ciaa1051
|
| 40 |
Omar J. BenMarzouk-Hidalgo, José M. Cisneros, Elisa Cordero, Almudena Martín-Peña, Berta Sanchez, Cecilia Martin-Gandul, Miguel A. Gentil, Miguel A. Gomez-Bravo, Ernesto Lage, Pilar Perez-Romero. Therapeutic Effect of the Acquisition of Cytomegalovirus-Specific Immune Response During Preemptive Treatment. Transplantation 2011; 91(8) doi: 10.1097/TP.0b013e3182115ba2
|
| 41 |
Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo, Krister Höckerstedt. Prospective study on CMV-reactivations under preemptive strategy in CMV-seropositive adult liver transplant recipients. Journal of Clinical Virology 2013; 57(1) doi: 10.1016/j.jcv.2013.01.013
|
| 42 |
Balázs Nemes, György Gámán, Attila Doros. Biliary complications after liver transplantation. Expert Review of Gastroenterology & Hepatology 2015; 9(4) doi: 10.1586/17474124.2015.967761
|
| 43 |
Romil Saxena, M. Isabel Fiel. Practical Hepatic Pathology: a Diagnostic Approach. 2018; doi: 10.1016/B978-0-323-42873-6.00038-X
|
| 44 |
Leila Jalilsani, Ramin Yaghobi, Bita Geramizadeh, Afsoon Afshari, MohammadHossein Karimi. A New Duplication in 668 to 672 Sites of UL54 Gene in Cytomegalovirus Ganciclovir Resistant Liver Transplanted Patients. Jundishapur Journal of Microbiology 2023; 16(9) doi: 10.5812/jjm-137970
|
| 45 |
Salman Khan, Timothy Sullivan, Mohsin Ali, Dallas Dunn, Gopi Patel, Shirish Huprikar. Low‐dose valganciclovir for cytomegalovirus prophylaxis in intermediate‐risk liver transplantation recipients. Liver Transplantation 2018; 24(5) doi: 10.1002/lt.25047
|
| 46 |
Paulina Cybulska, Andy Ni, Carolina Jimenez-Rivera. Viral Hepatitis: Retrospective Review in a Canadian Pediatric Hospital. ISRN Pediatrics 2011; 2011 doi: 10.5402/2011/182964
|
| 47 |
Marzieh Jamalidoust, Mandana Namayandeh, Gholamreza Pouladfar, Mazyar Ziyaeyan. Post-Liver Transplant Cytomegalovirus (CMV) Reactivation, Graft, and Patient Survival Rates in Iranian Population. Jundishapur Journal of Microbiology 2021; 14(3) doi: 10.5812/jjm.112775
|
| 48 |
Thomas V. Brogan, Francois Aspesberro. Diseases of the Liver in Children. 2014; doi: 10.1007/978-1-4614-9005-0_24
|
| 49 |
Ekta Gupta, Viniyendra Pamecha, Yogita Verma, Niteen Kumar, Archana Rastogi, Nadeem Hasnian, Ajeet Singh Bhadoria. Pre-Transplant Cytomegalovirus Immunoglobulin G Antibody Levels Could Prevent Severe Cytomegalovirus Infections Post-Transplant in Liver Transplant Recipients: Experience from a Tertiary Care Liver Centre. Indian Journal of Medical Microbiology 2017; 35(4) doi: 10.4103/ijmm.IJMM_17_201
|
| 50 |
Douglas Hunt, Sammy Saab. Zakim and Boyer's Hepatology. 2012; doi: 10.1016/B978-1-4377-0881-3.00049-8
|
| 51 |
Herlinda Reyes-Pérez, José Luis Sánchez-Huerta, Gustavo Varela-Fascinetto, José Carlos Romo-Vázquez, Abigail Morales-Sánchez, Ezequiel M. Fuentes-Pananá, Israel Parra-Ortega, Graciela Ramírez-Ramírez, Briceida López-Martínez. Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients. Boletín Médico Del Hospital Infantil de México (English Edition) 2016; 73(1) doi: 10.1016/S2444-3409(16)30012-7
|
| 52 |
Mark Pedersen, Anil Seetharam. Infections After Orthotopic Liver Transplantation. Journal of Clinical and Experimental Hepatology 2014; 4(4) doi: 10.1016/j.jceh.2014.07.004
|
| 53 |
Ângela Carvalho-Gomes, Almudena Cubells, Carmina Pallarés, Francisca Corpas-Burgos, Marina Berenguer, Victoria Aguilera, F. Xavier López-Labrador. Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation. Cellular Immunology 2022; 371 doi: 10.1016/j.cellimm.2021.104455
|
| 54 |
Eun-Ki Min, Juhan Lee, Su Jin Jeong, Deok-Gie Kim, Seung Hyuk Yim, Mun Chae Choi, Dong Jin Joo, Myoung Soo Kim, Jae Geun Lee. Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipients. International Journal of Infectious Diseases 2023; 131 doi: 10.1016/j.ijid.2023.04.387
|
| 55 |
Michelle Teodoro Alves, Sandra Simone Vilaça, Lara Carvalho Godoi, Leonides Rezende Júnior, Maria das Graças Carvalho, Franciele de Souza Silva, Flávia Loli Guimarães, Ana Paula Fernandes, Luci Maria SantAna Dusse, Karina Braga Gomes. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy. Clinica Chimica Acta 2014; 431 doi: 10.1016/j.cca.2014.01.039
|
| 56 |
D. Kroy, C. Trautwein. Immunsuppression nach Lebertransplantation. Der Gastroenterologe 2018; 13(3) doi: 10.1007/s11377-018-0252-y
|
| 57 |
Hanna L. Kleiboeker, Jillian L. Descourouez, Lucas T. Schulz, Didier A. Mandelbrot, Jon S. Odorico, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, Margaret R. Jorgenson. Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations. Annals of Pharmacotherapy 2023; 57(5) doi: 10.1177/10600280221118959
|
| 58 |
Safa Al-shamma, Mark Fox, Fiona Campbell, Paul Collins, Martin Lombard. Diarrhoea and weight loss in an immunosuppressed patient. Gut 2010; 59(9) doi: 10.1136/gut.2009.198986
|
| 59 |
O. M. Tsiroulnikova, I. V. Zhilkin, D. G. Akhaladze. CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS. Russian Journal of Transplantology and Artificial Organs 2016; 18(1) doi: 10.15825/1995-1191-2016-1-67-77
|
| 60 |
Sara Hafezi-Bakhtiari, Oyedele A. Adeyi. Evaluating and interpreting bile duct changes in liver allograft biopsies. Diagnostic Histopathology 2012; 18(2) doi: 10.1016/j.mpdhp.2011.11.001
|
| 61 |
Yong-Hee Kim. Human Cytomegalovirus Infection in Solid-Organ Transplantation. Journal of Bacteriology and Virology 2015; 45(1) doi: 10.4167/jbv.2015.45.1.11
|
| 62 |
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra. Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes. Transplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13898
|
| 63 |
Sang Hoon Han. Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies. Infection & Chemotherapy 2017; 49(3) doi: 10.3947/ic.2017.49.3.161
|
| 64 |
Ramin Raul Ossami Saidy, Stefanie Kollar, Zoltan Czigany, Luca Dittrich, Nathanael Raschzok, Brigitta Globke, Wenzel Schöning, Robert Öllinger, Georg Lurje, Johann Pratschke, Dennis Eurich, Deniz Uluk. Detrimental impact of immunosuppressive burden on clinical course in patients with Cytomegalovirus infection after liver transplantation. Transplant Infectious Disease 2024; 26(1) doi: 10.1111/tid.14196
|
| 65 |
Abdulkareem M Albekairy, Mohammad S Shawaqfeh, Shroug H Alharbi, Faisal Almuqbil, Mesfer A Alghamdi, Nataleen A Albekairy, Suhaib M Muflih, Abdulmalik Alkatheri. Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation. Transplant Research and Risk Management 2022; doi: 10.2147/TRRM.S366213
|
| 66 |
Carlos Cervera, Mercé Gurguí, Carlos Lumbreras. Factores de riesgo de la enfermedad por citomegalovirus en el receptor de un trasplante de órgano sólido. Enfermedades Infecciosas y Microbiología Clínica 2011; 29 doi: 10.1016/S0213-005X(11)70051-9
|
| 67 |
Maddalena Giannella, Michele Bartoletti, Pierluigi Viale. Abdominal Solid Organ Transplantation. 2015; doi: 10.1007/978-3-319-16997-2_2
|
| 68 |
Raymund R. Razonable, James Y. Findlay, Aisling O'Riordan, Gordon S. Burroughs, Mark R. Ghobrial, Banwari Agarwal, Andrew Davenport, Michael Gropper. Critical care issues in patients after liver transplantation. Liver Transplantation 2011; 17(5) doi: 10.1002/lt.22291
|
| 69 |
Tricia A Bal, Glenn Armstrong, Xiang Y Han. Evaluation of the IMMULITE® 2000 CMV IgM assay. Herpesviridae 2012; 3(1) doi: 10.1186/2042-4280-3-2
|
| 70 |
Bongkun Choi, Eun-Ju Chang. Biomarkers in Bone Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; doi: 10.1007/978-94-007-7693-7_40
|
| 71 |
Siddharth Sood, Craig Haifer, Lijia Yu, Julie Pavlovic, Paul J. Gow, Robert M. Jones, Kumar Visvanathan, Peter W. Angus, Adam G. Testro. Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation. Liver Transplantation 2015; 21(12) doi: 10.1002/lt.24216
|
| 72 |
J.G. Katsolis, W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, T.A. Gonwa, W.C. Hellinger. Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high‐risk patients. Transplant Infectious Disease 2013; 15(2) doi: 10.1111/tid.12050
|
| 73 |
A. Kahraman, K. Herzer. Labordiagnostische Überwachung nach Lebertransplantation. Der Gastroenterologe 2014; 9(2) doi: 10.1007/s11377-013-0836-5
|
| 74 |
Chalermrat Bunchorntavakul, K. Rajender Reddy. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver. Gastroenterology Clinics of North America 2020; 49(2) doi: 10.1016/j.gtc.2020.01.008
|
| 75 |
D.J. Winston, F. Saliba, E. Blumberg, M. Abouljoud, J.B. Garcia-Diaz, J.A. Goss, L. Clough, R. Avery, A.P. Limaye, B.G. Ericzon, M. Navasa, R.I. Troisi, H. Chen, S.A. Villano, M.E. Uknis. Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial. American Journal of Transplantation 2012; 12(11) doi: 10.1111/j.1600-6143.2012.04231.x
|
| 76 |
Maristela Pinheiro Freire, Isabel C. V. Soares Oshiro, Patricia Rodrigues Bonazzi, Thais Guimarães, Estela Regina Ramos Figueira, Telésforo Bacchella, Silvia Figueiredo Costa, Luiz Augusto Carneiro D'Albuquerque, Edson Abdala. Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: An analysis of the epidemiology, risk factors, and outcomes. Liver Transplantation 2013; 19(9) doi: 10.1002/lt.23682
|
| 77 |
Raymund R. Razonable. Cytomegalovirus infection after liver transplantation. Liver Transplantation 2010; 16(S2) doi: 10.1002/lt.22144
|
| 78 |
Lindsay A. Sobotka, Khalid Mumtaz, Michael R. Wellner, Sean G. Kelly, Lanla F. Conteh, A. James Hanje, Austin Schenk, Ashraf El-Hinnawi, Sylvester Black, Kenneth Washburn, Todd Pesavento, Reem Daloul, Anthony J. Michaels. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis. Annals of Hepatology 2021; 24 doi: 10.1016/j.aohep.2021.100318
|
| 79 |
Anita Verma, Anil Dhawan. Clinical Approach to the Management of Infections before and after Liver Transplantation. OBM Transplantation 2020; 4(02) doi: 10.21926/obm.transplant.2002108
|
| 80 |
|
| 81 |
Peter D. Yoon, Madhukar S. Patel, Carla F. Murillo Perez, Tommy Ivanics, Marco P.A.W. Claasen, Hala Muaddi, David Wallace, Bettina Hansen, Gonzalo Sapisochin, Yu-Chen Fan. Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis. Canadian Journal of Gastroenterology and Hepatology 2022; 2022 doi: 10.1155/2022/9932631
|
| 82 |
Alyssa K. Mezochow, Douglas E. Schaubel, Eliot G. Peyster, James D. Lewis, David S. Goldberg, Therese Bittermann. Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries. Transplant Infectious Disease 2024; 26(4) doi: 10.1111/tid.14317
|
| 83 |
J.M. Kim, S.J. Kim, J.-W. Joh, M. Shin, E.Y. Kim, J.I. Moon, G.O. Jung, G.-S. Choi, C.H.D. Kwon, S.-K. Lee. Preemptive Therapy in Adult Liver Transplant Recipients in CMV-Endemic Area. Transplantation Proceedings 2010; 42(3) doi: 10.1016/j.transproceed.2010.02.026
|
| 84 |
Mina M. Benjamin, Kevin J. Dasher, James F. Trotter. A Comparison of Outcomes Between OKT3 and Antithymocyte Globulin for Treatment of Steroid-Resistant Rejection in Hepatitis C Liver Transplant Recipients. Transplantation 2014; 97(4) doi: 10.1097/01.TP.0000435701.54019.98
|
| 85 |
|
| 86 |
Matteo Ravaioli, Flavia Neri, Tiziana Lazzarotto, Valentina Rosa Bertuzzo, Paolo Di Gioia, Giacomo Stacchini, Maria Cristina Morelli, Giorgio Ercolani, Matteo Cescon, Angela Chiereghin, Massimo Del Gaudio, Alessandro Cucchetti, Antonio D. Pinna. Immunosuppression Modifications Based on an Immune Response Assay. Transplantation 2015; 99(8) doi: 10.1097/TP.0000000000000650
|
| 87 |
J. Sun, G. Cao, L. Zhang, Y. Zhang, Z. Zhao, J. Hu, Y. Ji. Human Cytomegalovirus (CMV) UL97 D605E Mutation Has a Higher Prevalence in Infants With Primary CMV Infection Compared With Transplant Recipients With CMV Recurrence. Transplantation Proceedings 2012; 44(10) doi: 10.1016/j.transproceed.2012.06.069
|
| 88 |
Sara Gredmark-Russ, Cecilia Söderberg-Nauclér. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence 2012; 3(7) doi: 10.4161/viru.22239
|
| 89 |
Isabel Campos‐Varela, Emily A. Blumberg, Patricia Giorgio, Camille N. Kotton, Fauzi Saliba, Emmanuel Q Wey, Michael Spiro, Dimitri Aristotle Raptis, Federico Villamil. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations. Clinical Transplantation 2022; 36(10) doi: 10.1111/ctr.14631
|
| 90 |
|
| 91 |
Juan Jose Caston, Luis Castells, Evaristo Varo, Miguel Angel Gomez, Manuel de la Mata, Isabel Campos-Varela, Carlos Lumbreras, Luisa Gonzalez-Dieguez, Joan Fabregat, Ignacio Herrero, Magdalena Salcedo, Gloria Sanchez-Antolín, Julian Torre-Cisneros. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. Transplantation 2016; 100(3) doi: 10.1097/TP.0000000000000912
|
| 92 |
|
| 93 |
Keith W. Hamilton, Emily A. Blumberg. Cytomegalovirus Infection in Liver Transplant Recipients. Infectious Diseases in Clinical Practice 2012; 20(1) doi: 10.1097/IPC.0b013e31823c4817
|
| 94 |
A.M. Sampaio, A.C. Guardia, A. Milan, A.N. Sasaki, P.D. Andrade, S.H.A. Bonon, R.S.B. Stucchi, S.C. Botelho Costa, I.F.S.F. Boin. Co-infection and Clinical Impact of Human Herpesvirus 5 and 6 in Liver Transplantation. Transplantation Proceedings 2012; 44(8) doi: 10.1016/j.transproceed.2012.07.034
|
| 95 |
Marlotte A.A. van der Veer, Negina Nangrahary, Dennis A. Hesselink, Nicole S. Erler, Herold J. Metselaar, Teun van Gelder, Sarwa Darwish Murad. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation. Transplantation 2019; 103(11) doi: 10.1097/TP.0000000000002680
|
| 96 |
Steve Miller, Henrietta Seet, Yasmeen Khan, Carolyn Wright, Rohan Nadarajah. Comparison of QIAGEN Automated Nucleic Acid Extraction Methods for CMV Quantitative PCR Testing. American Journal of Clinical Pathology 2010; 133(4) doi: 10.1309/AJCPE5VZL1ONZHFJ
|
| 97 |
Zeynep Burcin Yilmaz, Funda Memisoglu, Sami Akbulut. Management of cytomegalovirus infection after liver transplantation. World Journal of Transplantation 2024; 14(3): 93209 doi: 10.5500/wjt.v14.i3.93209
|
| 98 |
|
| 99 |
Suresh B. Boppana, William J. Britt. Human Cytomegaloviruses. Methods in Molecular Biology 2014; 1119 doi: 10.1007/978-1-62703-788-4_17
|
| 100 |
Mark R. Schleiss, Stanley A. Plotkin. Plotkin's Vaccines. 2018; doi: 10.1016/B978-0-323-35761-6.00016-X
|
| 101 |
Carolin Lackner, Stefan G. Huebscher. Pathologie. Pathologie 2020; doi: 10.1007/978-3-642-04557-8_13
|
| 102 |
Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata, Shiv Kumar Sarin. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatology International 2024; 18(2) doi: 10.1007/s12072-023-10629-3
|
| 103 |
Veerendra Sandur, George Therapondos. Problem‐Based Approach to Gastroenterology and Hepatology. 2012; doi: 10.1002/9781444346381.ch16
|
| 104 |
Julia Engstrom-Melnyk, Pedro L. Rodriguez, Olivier Peraud, Raymond C. Hein. Current and Emerging Technologies for the Diagnosis of Microbial Infections. Methods in Microbiology 2015; 42 doi: 10.1016/bs.mim.2015.04.005
|
| 105 |
Hanlin L. Wang, Christopher D. Anderson, Sean Glasgow, William C. Chapman, Jeffrey S. Crippin, Mathew Augustine, Robert A. Anders, Andres Roma. Pathology of Solid Organ Transplantation. 2009; doi: 10.1007/978-3-540-79343-4_8
|
| 106 |
André Luís Conde Watanabe, Mateus Silva Feijó, Vinícius Paulo Lima de Menezes, Mayara Regina Galdino-Vasconcelos, Jorge Luis Salinas Caballero, Gustavo Ferreira, Fernando Jorge, Natália Trevizoli, Luiz Gustavo Diaz, Priscila Brizolla de Campos, Gabriel Cajá, Raquel Ullmann, Ana Virgínia Figueira, Tiago Morato, Adriano Moraes, Juan Rafael Branez Pereira, Marcelo Perosa. 500 Consecutive Liver Transplants: The Outcomes of a New Transplantation Program in the Middle West of Brazil. Transplantation Proceedings 2021; 53(1) doi: 10.1016/j.transproceed.2020.06.044
|
| 107 |
Suresh B. Boppana, William J. Britt. Human Cytomegaloviruses. Methods in Molecular Biology 2021; 2244 doi: 10.1007/978-1-0716-1111-1_19
|
| 108 |
Sameh Adel Fayek, Wana Mantipisitkul, Flavia Rasetto, Raghava Munivenkatappa, Rolf N. Barth, Benjamin Philosophe. Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients. HPB 2010; 12(10) doi: 10.1111/j.1477-2574.2010.00226.x
|
| 109 |
Panagiotis Tryphonopoulos, Debbie Weppler, Michele I. Morris, Cristina Russo, Seigo Nishida, David M. Levi, Jang Moon, Akin Tekin, Gennaro Selvaggi, Eddie Island, Leopoldo Arosemena, Phillip Ruiz, Andreas G. Tzakis. The Effect of Donor-Recipient Cytomegalovirus Serology on Adult Liver Transplantation: A Single Center Experience. Transplantation 2011; 92(9) doi: 10.1097/TP.0b013e31822eb1f9
|
| 110 |
Antonio Craxì, Rosa Di Stefano. Sherlock's Diseases of the Liver and Biliary System. 2011; doi: 10.1002/9781444341294.ch21
|
| 111 |
Zhaoxiang Du, Xingxing Yuan, Jie Yi, Manyu Li, Fangfang Dai, Xin Liu, Ning Liu, Haiqing Sun, Lili Zhang, Yanhua Yu. EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status. Journal of Medical Virology 2026; 98(2) doi: 10.1002/jmv.70837
|
| 112 |
Conrad Rauber, Miriam Awad, Ronald Koschny, Peter Sauer, Arianeb Mehrabi, Philip Gath, Karl-Heinz Weiss, Daniel Nils Gotthardt, Christian Rupp. Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study. Clinics and Research in Hepatology and Gastroenterology 2020; 44(1) doi: 10.1016/j.clinre.2019.05.005
|
| 113 |
|
| 114 |
Divya Dahiya, Chen‐Fang Lee, Kun‐Ming Chan, Ting‐Jung Wu, Hong‐Shiue Chou, Shin‐Shin Cheng, Wei‐Chen Lee. A short‐term preemptive treatment for cytomegalovirus infection in seropositive patients after liver transplantation. Journal of Hepato-Biliary-Pancreatic Sciences 2011; 18(1) doi: 10.1007/s00534-010-0286-0
|
| 115 |
Ryan H. Rochat, Gail J. Harrison. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 2025; doi: 10.1016/B978-0-323-82763-8.00159-X
|
| 116 |
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi. Textbook of Organ Transplantation. 2014; doi: 10.1002/9781118873434.ch82
|
| 117 |
Mark H. Kuniholm, Christina M. Parrinello, Kathryn Anastos, Michael Augenbraun, Michael Plankey, Marek Nowicki, Marion Peters, Elizabeth T. Golub, Nell Lurain, Alan L. Landay, Howard D. Strickler, Robert C. Kaplan, Julian W. Tang. Hepatitis C Viremia Is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected Women. PLoS ONE 2013; 8(4) doi: 10.1371/journal.pone.0061973
|
| 118 |
Christopher J. Damman, George B. McDonald. Transplant Infections. 2016; doi: 10.1007/978-3-319-28797-3_19
|
| 119 |
A. Verma, K. Palaniswamy, G. Cremonini, N. Heaton, A. Dhawan. Late cytomegalovirus infection in children: High incidence of allograft rejection and hepatitis in donor negative and seropositive liver transplant recipients. Pediatric Transplantation 2017; 21(3) doi: 10.1111/petr.12879
|
| 120 |
Michael S. Forman, Alexandra Valsamakis. Diagnostic Molecular Pathology in Practice. 2011; doi: 10.1007/978-3-642-19677-5_32
|
| 121 |
Nicolas J. Mueller, Jay A. Fishman. Medical Care of the Liver Transplant Patient. 2012; doi: 10.1002/9781444398441.ch34
|
| 122 |
Poornima Ramanan, Raymund R Razonable. Cytomegalovirus Infections in Solid Organ Transplantation: A Review. Infection & Chemotherapy 2013; 45(3) doi: 10.3947/ic.2013.45.3.260
|
| 123 |
Teresa Da Cunha, George Y. Wu. Cytomegalovirus Hepatitis in Immunocompetent and Immunocompromised Hosts. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00088
|
| 124 |
W. Ji, D.-S. Kim, S.-W. Jung, Y.-D. Yu, S.-O. Suh. Pre-emptive Therapy for the Cytomegalovirus Infection After Liver Transplantation in Endemic Areas and Its Optimal Diagnostic Method. Transplantation Proceedings 2013; 45(8) doi: 10.1016/j.transproceed.2013.08.042
|
| 125 |
Songpon Getsuwan, Pornthep Tanpowpong, Chatmanee Lertudomphonwanit, Jariya Chuthapisith, Napapat Butsriphum, Wasuntara Prabpram, Rarong Charoenmuang, Suporn Treepongkaruna. Health-Related Quality of Life in Pediatric Liver Transplant Recipients. Transplantation Proceedings 2021; 53(1) doi: 10.1016/j.transproceed.2020.02.175
|
| 126 |
Dibya Lochan Praharaj, Suprabhat Giri, Anil Chandra Anand, Bipadabhanjan Mallick, Preetam Nath, Saroj Kanta Sahu, Bramhadatta Pattnaik, Subrat Kumar Acharya, Yogesh Kumar Chawla. Viral hepatitis after liver transplantation: A brief overview. World Journal of Virology 2026; 15(1): 114321 doi: 10.5501/wjv.v15.i1.114321
|
| 127 |
IfeanyiChukwu O. Onor, Sarah B. Todd, Erika Meredith, Sebastian D. Perez, Aneesh K. Mehta, G. Marshall Lyon, Stuart J. Knechtle, Steven I. Hanish. Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transplant International 2013; 26(6) doi: 10.1111/tri.12101
|
| 128 |
P. Czarnecka, K. Czarnecka, O. Tronina, M. Durlik. Cytomegalovirus Disease After Liver Transplant—A Description of a Treatment-Resistant Case: A Case Report and Literature Review. Transplantation Proceedings 2018; 50(10) doi: 10.1016/j.transproceed.2018.05.014
|
| 129 |
Kyoung Yong Lee, Byung-Woo Yoo, Sung Soo Ahn, William Han Bae, Hyukmin Lee, Seung Min Jung, Sang-Won Lee, Yong-Beom Park, Jason Jungsik Song, Juliet V Spencer. Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR. PLOS ONE 2017; 12(7) doi: 10.1371/journal.pone.0181590
|
| 130 |
Antoni Rimola, Miquel Navasa. Evidence‐Based Gastroenterology and Hepatology. 2010; doi: 10.1002/9781444314403.ch43
|
| 131 |
Elizabeth G. Davis, David E. Freeman, Joanne Hardy. Equine Infectious Diseases. 2014; doi: 10.1016/B978-1-4557-0891-8.00001-4
|
| 132 |
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation. 2019; doi: 10.1007/978-3-319-96400-3_34
|
| 133 |
M. Isabel Fiel, Thomas Schiano. Acute cellular rejection and its sequelae developing in a 42‐year‐old man after liver transplantation†. Hepatology 2009; 50(2) doi: 10.1002/hep.23161
|
| 134 |
Norrapat Onpoaree, Anapat Sanpavat, Palittiya Sintusek. Cytomegalovirus infection in liver-transplanted children. World Journal of Hepatology 2022; 14(2): 338-353 doi: 10.4254/wjh.v14.i2.338
|
| 135 |
Raymund R Razonable. Immune-Based Therapies for Cytomegalovirus Infection. Immunotherapy 2010; 2(1) doi: 10.2217/imt.09.82
|
| 136 |
Jassin Rashidi‐Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant. Transplant Infectious Disease 2021; 23(3) doi: 10.1111/tid.13553
|
| 137 |
M. Papachristou, A. Fylaktou, M. Daoudaki, E. Cholongitas, T. Karampatakis, A. Anastasiou, G. Chatzika, F. Makrovasili, L. Vagiotas, K. Karakasi, I. Fouzas. Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation. Transplantation Proceedings 2019; 51(2) doi: 10.1016/j.transproceed.2019.01.074
|
| 138 |
Masami Minemura, Kazuto Tajiri, Yukihiro Shimizu. Liver involvement in systemic infection. World Journal of Hepatology 2014; 6(9): 632-642 doi: 10.4254/wjh.v6.i9.632
|
| 139 |
|
| 140 |
W. Gaya Shivega, Ali Olyaei, Madelaine A. Hack, Pushpa Neppala, George Zak, Alexandra Bolognese, C. Kristian Enestvedt, Erin Maynard, Willscott E. Naugler, David L. Scott, Oren Shaked, Elizabeth Swanson, Lynne Srasfeld, David C. Woodland, Christopher R. Connelly. The current status of CMV prophylaxis and treatment in liver transplant recipients: A single center study. Journal of Liver Transplantation 2025; 20 doi: 10.1016/j.liver.2025.100299
|
| 141 |
Bongkun Choi, Eun-Ju Chang. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; doi: 10.1007/978-94-007-7675-3_32
|
| 142 |
Christina B. Planitzer, Marcus D. Saemann, Hartwig Gajek, Maria R. Farcet, Thomas R. Kreil. Cytomegalovirus Neutralization by Hyperimmune and Standard Intravenous Immunoglobulin Preparations. Transplantation 2011; 92(3) doi: 10.1097/TP.0b013e318224115e
|
| 143 |
Kerstin Herzer, Christian P. Strassburg, Felix Braun, Cornelius Engelmann, Markus Guba, Frank Lehner, Silvio Nadalin, Andreas Pascher, Marcus N. Scherer, Andreas A. Schnitzbauer, Tim Zimmermann, Björn Nashan, Martina Sterneck. Selection and use of immunosuppressive therapies after liver transplantation: current German practice. Clinical Transplantation 2016; 30(5) doi: 10.1111/ctr.12708
|
| 144 |
Ann-Kristin Traska, Tobias Max Nowacki, Richard Vollenberg, Florian Rennebaum, Jörn Arne Meier, Tina Schomacher, Sara Noemi Reinartz Groba, Julia Fischer, Jonel Trebicka, Phil-Robin Tepasse. Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients. Cells 2024; 13(9) doi: 10.3390/cells13090741
|
| 145 |
Jackrapong Bruminhent, Raymund R Razonable. Management of cytomegalovirus infection and disease in liver transplant recipients. World Journal of Hepatology 2014; 6(6): 370-383 doi: 10.4254/wjh.v6.i6.370
|
| 146 |
Chian Yong Low, Seyed Mohammadmehdi Hosseini‐Moghaddam, Coleman Rotstein, Eberhard L. Renner, Shahid Husain. The effect of different immunoprophylaxis regimens on post‐transplant cytomegalovirus (CMV) infection in CMV‐seropositive liver transplant recipients. Transplant Infectious Disease 2017; 19(5) doi: 10.1111/tid.12736
|
| 147 |
Raymund Rabe Razonable. Management of Cytomegalovirus Infection After Renal Transplantation. Infectious Diseases in Clinical Practice 2009; 17(4) doi: 10.1097/IPC.0b013e31819b8d27
|
| 148 |
Omar Jesus BenMarzouk-Hidalgo, Elisa Cordero, Almudena Martín-Peña, Elena García-Prado, Miguel Angel Gentil, Miguel Angel Gomez-Bravo, Lydia Barrera-Pulido, Jose Miguel Cisneros, Pilar Perez-Romero. Prevention of cytomegalovirus disease using preemptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection. Antiviral Therapy 2009; 14(5) doi: 10.1177/135965350901400509
|
| 149 |
Siroj Dejhansathit, Adam Michael Miller, Attaya Suvannasankha. Multiple ‘doughnut’ granulomas in a liver transplant patient with CMV reactivation. BMJ Case Reports 2018; 11(1) doi: 10.1136/bcr-2018-227252
|
| 150 |
S. M. Miescher, T. M. Huber, M. Kühne, P. Lieby, D. R. Snydman, J. L. Vensak, M. Berger. In vitroevaluation of cytomegalovirus‐specific hyperimmune globulins vs. standard intravenous immunoglobulins. Vox Sanguinis 2015; 109(1) doi: 10.1111/vox.12246
|
| 151 |
Yuanyi Mang, Yang Gao, Yan Yang, Mei Dong, Qian Yang, Hong Li, Jianghua Ran, Li Li, Jun Ma, Guoyu Chen, Bin Yang, Ying Xie, Yunsong Wu, Yingpeng Zhao, Shengning Zhang. Experience on AMR Diagnosis and Treatment Following Liver Transplantation: Case Series. Transplantation Direct 2024; 10(4) doi: 10.1097/TXD.0000000000001598
|
| 152 |
Marta Bodro, Núria Sabé, Laura Lladó, Carme Baliellas, Jordi Niubó, Jose Castellote, Joan Fabregat, Antoni Rafecas, Jordi Carratalà. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients. Liver Transplantation 2012; 18(9) doi: 10.1002/lt.23460
|
| 153 |
A. Milan, A.M. Sampaio, A.C. Guardia, C.R. Pavan, P.D. Andrade, S.H.A. Bonon, S.C.B. Costa, E. Ataíde, I.F.S.F. Boin, R.S.B. Stucchi. Monitoring and Detection of Cytomegalovirus in Liver Transplant Recipients. Transplantation Proceedings 2011; 43(4) doi: 10.1016/j.transproceed.2011.02.031
|
| 154 |
W. Bosch, M.G. Heckman, N.N. Diehl, J.A. Shalev, S. Pungpapong, W.C. Hellinger. Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High-Risk Recipients. American Journal of Transplantation 2011; 11(10) doi: 10.1111/j.1600-6143.2011.03618.x
|
| 155 |
Blanca C Lizaola-Mayo, Eduardo A Rodriguez. Cytomegalovirus infection after liver transplantation. World Journal of Transplantation 2020; 10(7): 183-190 doi: 10.5500/wjt.v10.i7.183
|
| 156 |
Kathleen M. Doss, Catherine E. Kling, Madeleine R. Heldman, Nina Singh, Marilyn Wagener, Robert M. Rakita, Cynthia E. Fisher, Ajit P. Limaye. Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR). Transplant Infectious Disease 2023; 25(2) doi: 10.1111/tid.14015
|
| 157 |
Wendelyn Bosch, Michael G. Heckman, Surakit Pungpapong, Nancy N. Diehl, Jefree A. Shalev, Walter C. Hellinger. Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation. Transplantation 2012; 93(7) doi: 10.1097/TP.0b013e3182472876
|
| 158 |
Alyson N. Fox, Robert S. Brown. Yamada' s Textbook of Gastroenterology. 2015; doi: 10.1002/9781118512074.ch108
|
| 159 |
Wojciech Błogowski. Facial transplantation as an option in reconstructive surgery: no mountains too high?. ANZ Journal of Surgery 2009; 79(12) doi: 10.1111/j.1445-2197.2009.05140.x
|
| 160 |
Joachim Denner, Annette Mankertz. Porcine Circoviruses and Xenotransplantation. Viruses 2017; 9(4) doi: 10.3390/v9040083
|
| 161 |
Romil Saxena, Swan N. Thung. Practical Hepatic Pathology: A Diagnostic Approach. 2011; doi: 10.1016/B978-0-443-06803-4.00042-3
|
| 162 |
Prem N. Patel, Ahmed M. Alkaliby, Mitul C. Mehta, Angeline L. Wang. CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases. Allergy, Asthma & Clinical Immunology 2023; 19(1) doi: 10.1186/s13223-023-00817-z
|
| 163 |
|
| 164 |
Timothy M. Schmitt, Melissa Phillips, Robert G. Sawyer, Patrick Northup, Klaus D. Hagspiel, Timothy L. Pruett, Hugo J. R. Bonatti. Anti-thymocyte Globulin for the Treatment of Acute Cellular Rejection Following Liver Transplantation. Digestive Diseases and Sciences 2010; 55(11) doi: 10.1007/s10620-010-1149-x
|
| 165 |
Manav Wadhawan, Subash Gupta, Neerav Goyal, Karisangal R. Vasudevan, Kausar Makki, Reetika Dawar, Raman Sardana, Nand Lal, Ajay Kumar. Cytomegalovirus infection: Its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: A single-center experience. Liver Transplantation 2012; 18(12) doi: 10.1002/lt.23540
|
| 166 |
Amy W. Liu, Kamonwan Jutivorakool, Cynthia E. Fisher, Robert M. Rakita, Jorge D. Reyes, Renuka B. Bhattacharya, Keith R. Jerome, Ajit P. Limaye. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients. Transplantation 2018; 102(4) doi: 10.1097/TP.0000000000002029
|
| 167 |
Richard R Watkins, Tracy L Lemonovich, Raymund R Razonable. Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Review of Clinical Immunology 2012; 8(4) doi: 10.1586/eci.12.25
|
| 168 |
Jasmine Riviere Marcelin, Elena Beam, Raymund R Razonable. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World Journal of Gastroenterology 2014; 20(31): 10658-10667 doi: 10.3748/wjg.v20.i31.10658
|
| 169 |
|